Tubacin, an inhibitor of HDAC6, promoted the extracellular release of CD133+ EVs from human FEMX-I metastatic melanoma and Caco-2 colorectal carcinoma cells, leading to the downregulation of intracellular CD133 [30]. This evidence concerns the gene HDAC6 and colorectal carcinoma.